NYSE:GRDN Guardian Pharmacy Services (GRDN) Stock Price, News & Analysis $21.56 -0.57 (-2.58%) Closing price 05/28/2025 03:59 PM EasternExtended Trading$21.47 -0.09 (-0.42%) As of 05/28/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About Guardian Pharmacy Services Stock (NYSE:GRDN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get GRDN alerts:Sign Up Key Stats Today's Range$21.18▼$22.2550-Day Range$20.11▼$26.4452-Week Range$14.16▼$26.91Volume206,889 shsAverage Volume166,511 shsMarket Capitalization$1.36 billionP/E RatioN/ADividend YieldN/APrice Target$25.67Consensus RatingBuy Company OverviewGuardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.Read More… Guardian Pharmacy Services Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks19th Percentile Overall ScoreGRDN MarketRank™: Guardian Pharmacy Services scored higher than 19% of companies evaluated by MarketBeat, and ranked 873rd out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingBuy Consensus RatingGuardian Pharmacy Services has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageGuardian Pharmacy Services has only been the subject of 2 research reports in the past 90 days.Read more about Guardian Pharmacy Services' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-3.45% Earnings GrowthEarnings for Guardian Pharmacy Services are expected to decrease by -3.45% in the coming year, from $0.87 to $0.84 per share.Read more about Guardian Pharmacy Services' valuation and earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for GRDN. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGuardian Pharmacy Services does not currently pay a dividend.Dividend GrowthGuardian Pharmacy Services does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for GRDN. News and Social Media2.1 / 5News Sentiment0.74 News SentimentGuardian Pharmacy Services has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Guardian Pharmacy Services this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 1 people have added Guardian Pharmacy Services to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Guardian Pharmacy Services insiders have not sold or bought any company stock.Percentage Held by Insiders63.71% of the stock of Guardian Pharmacy Services is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about Guardian Pharmacy Services' insider trading history. Receive GRDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardian Pharmacy Services and its competitors with MarketBeat's FREE daily newsletter. Email Address GRDN Stock News HeadlinesGuardian Pharmacy Services (NYSE:GRDN) Lowered to Hold Rating by Wall Street ZenMay 24, 2025 | americanbankingnews.comGuardian Pharmacy Services Announces Pricing of Underwritten Public Offering of Class A Common StockMay 22, 2025 | businesswire.comURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold. May 29, 2025 | Golden Portfolio (Ad)Guardian Pharmacy announces public stock offeringMay 21, 2025 | investing.comTruist Financial Reiterates Buy Rating for Guardian Pharmacy Services (NYSE:GRDN)May 21, 2025 | americanbankingnews.comGuardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common StockMay 20, 2025 | businesswire.comA Look At The Intrinsic Value Of Guardian Pharmacy Services, Inc. (NYSE:GRDN)May 16, 2025 | uk.finance.yahoo.comGuardian Pharmacy Services Expands Midwest Long-Term Care Footprint with Wichita, Kansas ...May 14, 2025 | gurufocus.comSee More Headlines GRDN Stock Analysis - Frequently Asked Questions How have GRDN shares performed this year? Guardian Pharmacy Services' stock was trading at $20.26 on January 1st, 2025. Since then, GRDN shares have increased by 6.4% and is now trading at $21.56. View the best growth stocks for 2025 here. How were Guardian Pharmacy Services' earnings last quarter? Guardian Pharmacy Services, Inc. (NYSE:GRDN) posted its quarterly earnings results on Monday, May, 12th. The company reported $0.21 earnings per share for the quarter, missing analysts' consensus estimates of $0.22 by $0.01. The company earned $329.31 million during the quarter, compared to the consensus estimate of $321.21 million. Read the conference call transcript. When did Guardian Pharmacy Services IPO? Guardian Pharmacy Services (GRDN) raised $102 million in an IPO on Thursday, September 26th 2024. The company issued 6,800,000 shares at $14.00-$16.00 per share. Raymond James, Stifel and Truist Securities served as the underwriters for the IPO. Who are Guardian Pharmacy Services' major shareholders? Guardian Pharmacy Services' top institutional shareholders include Brown Advisory Inc. (2.53%), Wellington Management Group LLP (0.73%), Woodline Partners LP (0.67%) and Driehaus Capital Management LLC (0.64%). Insiders that own company stock include Thomas J Salentine Jr and Steven D Cosler. View institutional ownership trends. How do I buy shares of Guardian Pharmacy Services? Shares of GRDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Guardian Pharmacy Services own? Based on aggregate information from My MarketBeat watchlists, some other companies that Guardian Pharmacy Services investors own include UnitedHealth Group (UNH) and Meta Platforms (META). Company Calendar Last Earnings5/12/2025Today5/29/2025Next Earnings (Estimated)8/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Drug stores & proprietary stores Sub-IndustryRetail Current SymbolNYSE:GRDN Previous SymbolNYSE:GRDN CIK1802255 Webguardianpharmacy.com Phone(404) 810-0089FaxN/AEmployees3,200Year FoundedN/APrice Target and Rating Average Stock Price Target$25.67 High Stock Price Target$28.00 Low Stock Price Target$21.00 Potential Upside/Downside+19.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.28 billion Price / Sales1.06 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares63,287,000Free FloatN/AMarket Cap$1.36 billion OptionableN/A BetaN/A The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NYSE:GRDN) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardian Pharmacy Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardian Pharmacy Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.